Common questions about Нафтадерм (FAQ)
Q: Is Нафтадерм considered a steroid-free treatment?
The active ingredient in Нафтадерм is Petroleum Naphtalan, which is classified as a dermatotropic agent. Official regulatory documentation identifies the active component as an oil derivative and does not categorize the product as a corticosteroid or contain any steroid components.
Q: Does Нафтадерм help with eczema and neurodermatitis?
Studies and official information indicate that the product has been researched for use in chronic skin conditions, including atopic dermatitis (eczema) and neurodermatitis. Its therapeutic actions include anti-inflammatory and antipruritic (anti-itching) effects. Studies monitored physical signs in individuals with these conditions.
Q: Can Нафтадерм be used for psoriasis on the scalp?
The official instructions specify applying the preparation to the affected skin areas. Use is subject to the general rule that the skin surface must be intact and free of acute inflammation. For specific application sites like the scalp, it is best to consult the prescribing physician.
Q: Can Нафтадерм cause skin dryness or irritation over time?
Yes, regulatory information lists local reactions at the application site. Officially documented adverse effects include Xeroderma (skin dryness), a local burning sensation, and the potential for local hypersensitivity reactions.
Q: Can Нафтадерм be used on sensitive areas of the body, like the face?
Official instructions do not specifically prohibit application to the face. However, it is strictly contraindicated (should not be used) on skin that has acute inflammation or is non-intact. Application to the face or other sensitive areas should be discussed with a healthcare professional.
Q: Are there any known interactions between Нафтадерм and oral antibiotics?
According to the official product information, Нафтадерм is a topical product and is not associated with systemic drug-drug interactions. This means it is not expected to affect the clearance or plasma concentration of medicines taken orally, such as antibiotics.
Q: Can Нафтадерм be used on broken or infected skin?
No, the official safety restrictions strictly contraindicate the preparation’s use on areas with acute inflammation or on non-intact skin, including open wounds. The official label specifies that the preparation must only be applied to intact skin surfaces.
Q: Does Нафтадерм thin the skin like some corticosteroid creams?
The mechanism of action involves the regulation of epidermal cell proliferation (how skin cells grow). Importantly, skin thinning (atrophy) is not listed as an officially documented local or systemic adverse effect in the regulatory safety profile.
Q: Is there a maximum recommended duration for using Нафтадерм?
The standard duration of the treatment course is generally specified as 3 to 4 weeks. However, the final length of the regimen is determined on an individualized basis by a healthcare professional.
Q: Can I apply makeup or sunscreen over an area treated with Нафтадерм?
The official label states the preparation increases the permeability of the skin for other medicinal products applied to the same area. This effect should be considered when applying any other product, including cosmetics or sunscreens, to the treated skin.
Q: What should I do if my skin gets worse after starting to use Нафтадерм?
If you experience a severe reaction, official labeling advises that the use of the preparation should be discontinued. This is specifically noted for pronounced local allergic or hypersensitivity reactions. Any worsening of symptoms should be discussed with a healthcare professional.
Q: Why do some people use Нафтадерм for problems other than eczema or psoriasis?
Beyond the most common indications, the compound has been studied in other contexts, including general dermatitis, neurodermatitis, and for effects related to the rate of epithelialization (skin healing).
Q: Why is Naftalan oil, the active component, used in skin treatment?
The therapeutic use is based on the oil's unique physiological actions. The compound is supported by pharmacological studies to have anti-inflammatory, antipruritic (anti-itching), and keratoplastic (skin-regenerating) effects.
Q: What scientific literature supports the use of Naftalan preparations in dermatology?
Research has included small-scale open-label trials and non-comparative observational studies. These studies tracked outcomes like the Psoriasis Area Severity Index (PASI) to grade the extent of improvement in patients with chronic skin conditions.
Q: Is Нафтадерм available without a prescription in some regions?
Yes, in the region of its primary regulation, the medicine is classified as a non-prescription (OTC) medicinal preparation.
Q: Is the effect of Нафтадерм permanent, or do symptoms return after stopping use?
Official regulatory texts note that long-term effects are not fully established. There is limited information available regarding the durability of any observed response or the overall maintenance of skin status in long-term follow-up.
Q: What kind of skin healing properties does Нафтадерм have?
The preparation is supported to have keratoplastic effects, meaning it helps normalize the renewal of the outer skin layer. Research has also explored the compound's relevance to the rate of epithelialization, or the process of skin healing.
Q: What are the typical expected results when using Нафтадерм for chronic eczema?
Studies monitored specific physical signs of chronic skin conditions. The results focused on changes in signs like erythema (redness), desquamation (scaling), and plaque infiltration (thickness) during the short-term study period.
Q: What patient groups should definitely avoid using Нафтадерм?
The medicine is strictly contraindicated for individuals diagnosed with severe systemic conditions such as Renal Insufficiency (kidney failure), Hemorrhagic Syndrome, Severe Anemia, or those with known hypersensitivity to the ingredients.
Q: Is there a concern about systemic absorption with long-term, large-area application of Нафтадерм?
Regulatory documents establish the medicine is not associated with systemic drug-drug interactions. However, constraints are listed for patients with specific systemic illnesses, such as severe renal impairment. Patients with concerns about large-area use should consult a healthcare professional.
Q: Where is the active ingredient in Нафтадерм sourced from?
The active ingredient, Petroleum Naphtalan, is a refined distillate of a specialized type of heavy crude oil. This source material has traditionally been obtained from the Naftalan region of Azerbaijan.
